Table of Contents
Table of Contents
Preface
Chapter 1: Tacrolimus Properties and Formulations: Potential Impact of Product Quality on Safety and Efficacy
(Ziyaur Rahman, Ahmed Zidan and Mansoor A. Khan, Division of Product Quality and Research, Center of Drug Evaluation and Research, Food and Drug Administration, MD, USA, and others)
Chapter 2: Tacrolimus: A Clinician’s Perspective on What is Important
(Preeti Singhai and Jeremy Chapman, Centre for Transplant and Renal Research, University of Sydney, Westmead Hospital, Westmead, Australia)
Chapter 3: Pharmacogenetics of Tacrolimus in Solid Organ Transplantation: One More Approach to Manage its Effectiveness and Safety
(María José Herrero, Virginia Bosó, Jesús Ruiz, Luis Rojas, Sergio Bea, Jaime Sánchez Plumed, Julio Hernández, José Luis Poveda and Salvador F. Aliño, Pharmacogenetics Unit, Service of Pharmacy and IIS La Fe, Politechnic University Hospital La Fe, Valencia, Spain, and others)
Chapter 4: Tacrolimus: A Review of its Efficacy and Potential as Monotherapy in Liver Transplantation
(Ebube Bakosi, Emily Bakosi and Henkie Tan, The Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA, and others)
Chapter 5: Tacrolimus and Liver and Kidney Regeneration
(D. Kahn, Department of Surgery, University of Cape Town, South Africa)
Chapter 6: Topical Tacrolimus: Efficacy and Tolerability
(Frederick J. Lee and Constance H. Katelaris, Clinical Research Program, St. Vincent’s Centre for Applied Medical Research, Sydney, Australia, and others)
Chapter 7: Influence of Tacrolimus on the Healing of Colonic Anastomoses in Rats under Artificially Obstructive Conditions
(D. Raptis, M.G. Pramateftakis, I. Mantzoros, D. Kanellos and I. Kanellos, Surgical Department, Friedrich-Alexander University of Erlangen-Nuremberg, Germany, and others)
Chapter 8: Effect of Tacrolimus on Thrombotic-Related Mechanisms
(José J. Zamorano-León, Antonio J. López-Farré, Javier Modrego Martín, Pablo Rodríguez-Sierra and Alberto Barrientos Guzmán, Cardiovascular Research Unit of Cardiology and Nephrology Departments, Hospital Clínico San Carlos de Madrid, Spain)
Chapter 9: Tacrolimus as a Therapeutic Drug in Hereditary Hemorrhagic Telangiectasia (HHT)
(V. Albiñana, L. Velasco, R. Zarrabeitia and L.M. Botella, Center for Biological Investigations (CIB), Spanish Research Council, Madrid, Spain, and others)
Index
